The world leader in clinically tested artificial pancreas solutions, TypeZero Technologies is a digital health and personalized medicine company dedicated to revolutionizing the treatment and management of diabetes. TypeZero is combining next-generation data science techniques, proven metabolic models, and modern engineering practices to develop customized analytics tools and blood glucose control solutions to help people with type 1 and type 2 diabetes improve their health and lives. TypeZero’s current solutions include a smartphone-based artificial pancreas system, therapy optimization tools for health care providers, and advisory applications for smart insulin pens. To learn more, visit www.typezero.com.
Looking for a particular TypeZero Technologies Inc. employee's phone or email?
The TypeZero Technologies Inc. annual revenue was $2.2 million in 2026.
Colin Steele is the CTO of TypeZero Technologies Inc..
1 people are employed at TypeZero Technologies Inc..
TypeZero Technologies Inc. is based in Charlottesville, Virginia.
The NAICS codes for TypeZero Technologies Inc. are [518, 51].
The SIC codes for TypeZero Technologies Inc. are [737, 73, 38, 384].